Advertisement.

SLDB Projected Dividend Yield

Solid Biosciences Inc ( NASDAQ : SLDB )

Solid Biosciences is a life science company focused on developing a portfolio of neuromuscular and cardiac programs, including SGT-003, a gene therapy candidate, for the treatment of Duchenne muscular dystrophy; AVB-202-TT, a gene therapy program for the treatment of Friedreich's ataxia; AVB-401, a gene therapy program for the treatment of BCL-2-associated athanogene 3-mediated dilated cardiomyopathy (DCM); and additional assets for the treatment of undisclosed cardiac diseases. Co. also has two pipeline programs, AVB-501 for DCM and AVB-601 for hypertrophic, that are both in preclinical development to treat undisclosed cardiac indications.

20 YEAR PERFORMANCE RESULTS

SLDB Dividend History Detail
SLDB Dividend News
SLDB Competitors News

# of Shares: 0

Closing Price: 4.91

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000